Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioharvest Sciences (BHST) Current Deferred Revenue (2023 - 2025)

Historic Current Deferred Revenue for Bioharvest Sciences (BHST) over the last 3 years, with Q3 2025 value amounting to $438000.0.

  • Bioharvest Sciences' Current Deferred Revenue changed N/A to $438000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $438000.0, marking a year-over-year change of. This contributed to the annual value of $906000.0 for FY2024, which is 2618.38% up from last year.
  • Latest data reveals that Bioharvest Sciences reported Current Deferred Revenue of $438000.0 as of Q3 2025.
  • In the past 5 years, Bioharvest Sciences' Current Deferred Revenue registered a high of $1.1 million during Q1 2025, and its lowest value of $438000.0 during Q3 2025.
  • Over the past 3 years, Bioharvest Sciences' median Current Deferred Revenue value was $906000.0 (recorded in 2024), while the average stood at $847833.3.
  • Its Current Deferred Revenue has fluctuated over the past 5 years, first surged by 2618.38% in 2024, then surged by 2461.37% in 2025.
  • Over the past 3 years, Bioharvest Sciences' Current Deferred Revenue (Quarter) stood at $718000.0 in 2023, then increased by 26.18% to $906000.0 in 2024, then plummeted by 51.66% to $438000.0 in 2025.
  • Its Current Deferred Revenue stands at $438000.0 for Q3 2025, versus $990000.0 for Q2 2025 and $1.1 million for Q1 2025.